Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer

Details for Australian Patent Application No. 2010234562 (hide)

Owner Eisai Inc.

Inventors Belyakov, Sergei; Duvall, Bridget; Ferraris, Dana; Hamilton, Gregory; Vaal, Mark

Agent Fisher Adams Kelly

Pub. Number AU-A-2010234562

PCT Pub. Number WO2010/118013

Priority 61/167,117 06.04.09 US

Filing date 6 April 2010

Wipo publication date 14 October 2010

International Classifications

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/7052 (2006.01)

A61K 31/706 (2006.01)

A61K 31/7068 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

10 November 2011 PCT application entered the National Phase

  PCT publication WO2010/118013 Priority application(s): WO2010/118013

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010234569-Apparatus and method to control material converting and envelope stuffing

2010234547-Air duct and toner cartridge using same